efavirenz and Torsade de Pointes

efavirenz has been researched along with Torsade de Pointes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdelhady, AM; Desta, Z; Jaynes, HA; Kreutz, Y; Lu, JB; Overholser, BR; Robarge, JD; Shugg, T; Thong, N; Tisdale, JE	1
Castillo, R; El-Sherif, N; Pedalino, RP; Turitto, G	1

Trials

1 trial(s) available for efavirenz and Torsade de Pointes

Article	Year
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B666 Allele Carriers. Journal of cardiovascular electrophysiology, 2016, Volume: 27, Issue:10 Topics: Action Potentials; Adolescent; Adult; Alkynes; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Dose-Response Relationship, Drug; Electrocardiography; ERG1 Potassium Channel; Female; Gene Frequency; Genotype; Healthy Volunteers; Heart Rate; HEK293 Cells; Homozygote; Humans; Male; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Potassium Channel Blockers; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Time Factors; Torsades de Pointes; Transfection; Young Adult	2016

Article

Year

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.

Journal of cardiovascular electrophysiology, 2016, Volume: 27, Issue:10

Topics: Action Potentials; Adolescent; Adult; Alkynes; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Dose-Response Relationship, Drug; Electrocardiography; ERG1 Potassium Channel; Female; Gene Frequency; Genotype; Healthy Volunteers; Heart Rate; HEK293 Cells; Homozygote; Humans; Male; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Potassium Channel Blockers; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Time Factors; Torsades de Pointes; Transfection; Young Adult

2016

Other Studies

1 other study(ies) available for efavirenz and Torsade de Pointes

Article	Year
Efavirenz-associated QT prolongation and Torsade de Pointes arrhythmia. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:6 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiac Pacing, Artificial; Cyclopropanes; Female; HIV Infections; Humans; Long QT Syndrome; Middle Aged; Oxazines; Time Factors; Torsades de Pointes	2002